89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer
Clinical trial NCT03065764 · UNKNOWN
Trial details
- NCT number
- NCT03065764
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-20
- Primary completion
- 2019-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.